Yahoo Finance - GhSink

Yahoo Finance

Axon Enterprise, Inc. (AXON) is a Buy Following Pull back and amid $3B Scale Prospects: TD Cowen

Axon Enterprise, Inc. (AXON) is a Buy Following Pu...

1 week ago 8

Stifel Asserts Buy Stance on Hillman Solutions Corp. (HLMN) on Home Improvement Market Recovery

Stifel Asserts Buy Stance on Hillman Solutions Cor...

1 week ago 7

UBS Cautious on NuScale Power Corporation (SMR) amid Near Term Headwinds

UBS Cautious on NuScale Power Corporation (SMR) am...

1 week ago 10

CNH Industrial N.V. (CNH) Earns Moderate Buy Consensus, JPMorgan Downgrades on Weaker Outlook

CNH Industrial N.V. (CNH) Earns Moderate Buy Conse...

1 week ago 11

William Blair Reiterates Outperform on Sterling Infrastructure Inc. (STRL), Citing Project Execution and Growth Pipeline

William Blair Reiterates Outperform on Sterling In...

1 week ago 10

BTIG Reiterates Buy on AeroVironment, Inc. (AVAV) with $415 Price Target Amid Strong Analyst Consensus

BTIG Reiterates Buy on AeroVironment, Inc. (AVAV) ...

1 week ago 11

RBC Stays Bullish on Aecom (ACM) While Baird Flags Long-Term Revenue Pressure From AI Rollout

RBC Stays Bullish on Aecom (ACM) While Baird Flags...

1 week ago 11

JPMorgan Downgrades Sanofi (SNY) to EUR 95 from EUR 105

JPMorgan Downgrades Sanofi (SNY) to EUR 95 from EU...

1 week ago 7

Novartis AG (NVS) Gets Upgraded to Overweight from Neutral by JPMorgan

Novartis AG (NVS) Gets Upgraded to Overweight from...

1 week ago 7

J.P. Morgan Maintains a Sell Rating on GSK plc (GSK)

J.P. Morgan Maintains a Sell Rating on GSK plc (GS...

1 week ago 7

Argus Downgrades Novo Nordisk A/S (NVO) to Hold From Buy

Argus Downgrades Novo Nordisk A/S (NVO) to Hold Fr...

1 week ago 8

Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In?

Why is AstraZeneca PLC (AZN) One of the Best Pharm...

1 week ago 7

Jefferies Remains Bullish on Bristol-Myers Squibb Company (BMY)

Jefferies Remains Bullish on Bristol-Myers Squibb ...

1 week ago 7

Pfizer Inc. (PFE) Announces Results from the Phase 3 BASIS Study Evaluating HYMPAVZI

Pfizer Inc. (PFE) Announces Results from the Phase...

1 week ago 7

Guggenheim Lifts PT on Merck & Co. (MRK) to $122 From $104

Guggenheim Lifts PT on Merck & Co. (MRK) to $122 F...

1 week ago 7

Eli Lilly and Company (LLY) Announces Results From Phase 3 BRUIN CLL-314 Trial Evaluating Jaypirca Versus Imbruvica

Eli Lilly and Company (LLY) Announces Results From...

1 week ago 7

Dropbox CFO Timothy Regan to step down

Dropbox CFO Timothy Regan to step down

1 week ago 7

These Could Be 3 of the Best Stocks to Own in 2026

These Could Be 3 of the Best Stocks to Own in 2026...

1 week ago 8